Recent events
Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.
The events that are rare across the whole market - bankruptcies, auditor changes, delisting notices, completed acquisitions, and a company saying its published accounts were wrong.
| Date | Company | Event | Filing |
|---|---|---|---|
| Aktis Oncology, Inc. AKTS | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Aldabra 4 Liquidity Opportunity Vehicle, Inc. ALOV | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Allarity Therapeutics, Inc. ALLR | Annual report filed FY to 2025-12-31 | Form 10-K | |
| American Exceptionalism Acquisition Corp. A AEXA | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Annexon, Inc. ANNX | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Aptera Motors Corp SEV | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Aspire Biopharma Holdings, Inc. ASBP | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Aura Biosciences, Inc. AURA | Annual report filed FY to 2025-12-31 | Form 10-K | |
| BGSF, INC. BGSF | Annual report filed FY to 2025-12-28 | Form 10-K | |
| BITMINE IMMERSION TECHNOLOGIES, INC. BMNR | Acquisition or disposal completed Item 2.01 | Form 8-K | |
| BOSTON OMAHA Corp BOC | Annual report filed FY to 2025-12-31 | Form 10-K | |
| BT Brands, Inc. BTBD | Annual report filed FY to 2025-12-28 | Form 10-K | |
| Bicara Therapeutics Inc. BCAX | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Bio Green Med Solution, Inc. BGMS | Annual report filed FY to 2025-12-31 | Form 10-K | |
| CISO Global, Inc. CISO | Annual report filed FY to 2025-12-31 | Form 10-K | |
| CVD EQUIPMENT CORP CVV | Annual report filed FY to 2025-12-31 | Form 10-K | |
| CXApp Inc. CXAI | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Change Agents Corporation. CHGA | Annual report filed FY to 2025-12-31 | Form 10-K | |
| CitroTech Inc. CITR | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Curanex Pharmaceuticals Inc CURX | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Cyclerion Therapeutics, Inc. CYCN | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Cytosorbents Corp CTSO | Annual report filed FY to 2025-12-31 | Form 10-K | |
| DYADIC INTERNATIONAL INC DYAI | Delisting notice Item 3.01 | Form 8-K | |
| DeFi Development Corp. DFDV | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Designer Brands Inc. DBI | Annual report filed FY to 2026-01-31 | Form 10-K | |
| DiaMedica Therapeutics Inc. DMAC | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Dragonfly Energy Holdings Corp. DFLI | Annual report filed FY to 2025-12-31 | Form 10-K | |
| EXOZYMES INC. EXOZ | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Eikon Therapeutics, Inc. EIKN | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Ensysce Biosciences, Inc. ENSC | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Fabric.AI, Inc. FABC | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Faeth Therapeutics, Inc. FTH | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Falcon's Beyond Global, Inc. FBYD | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Fathom Holdings Inc. FTHM | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Fermi Inc. FRMI | Annual report filed FY to 2025-12-31 | Form 10-K | |
| GBank Financial Holdings Inc. GBFH | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Genprex, Inc. GNPX | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Glucotrack, Inc. GCTK | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Gores Holdings X, Inc. / CI GTEN | Annual report filed FY to 2025-12-31 | Form 10-K | |
| Greenlane Holdings, Inc. GNLN | Delisting notice Item 3.01 | Form 8-K |
Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.